Cardio Diagnostics Holdings, Inc. Logo

Cardio Diagnostics Holdings, Inc.

AI-powered epigenetic and genetic tests for early detection of heart disease risk.

CDIO | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
311 W. SUPERIOR STREET, 60645 CHICAGO
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Cardio Diagnostics Holdings, Inc. is a biotechnology company specializing in artificial intelligence-driven cardiovascular medicine. The company develops and commercializes clinical tests that utilize a proprietary combination of epigenetics, genetics, and AI to enable the early detection and prevention of heart disease. Its core mission is to make cardiovascular care more accessible, personalized, and precise. By analyzing genetic and epigenetic markers, Cardio Diagnostics provides deep insights into an individual's risk of a heart attack, empowering healthcare providers with actionable intelligence for proactive and personalized patient management.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cardio Diagnostics Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cardio Diagnostics Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cardio Diagnostics Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Celyad Oncology SA Logo
Clinical-stage biotech developing CAR T therapies for solid and blood cancers.
Belgium CYAD
CENTAUR MEDIA PLC Logo
Provides business intelligence, learning, and consultancy for marketing & legal professionals.
United Kingdom CAU
Century Therapeutics, Inc. Logo
Developing iPSC-derived, off-the-shelf cell therapies for cancer & autoimmune diseases.
United States of America IPSC
Cereno Scientific AB Logo
Develops epigenetic therapies for rare cardiovascular and pulmonary diseases.
Sweden CRNO
CERES INC. Logo
Develops online media platforms connecting consumers with advertisers through a rewards system.
Japan 3696
Certara, Inc. Logo
Accelerating new medicines with biosimulation software and services for pharma & biotech.
United States of America CERT
CEVA INC Logo
Licensor of DSP, AI, wireless, and sensing IP for low-power, smart edge devices.
United States of America CEVA
Chabiotech Co.,Ltd. Logo
Develops cell/gene therapies and offers CDMO, biobanking, and genomics services for rare diseases.
South Korea 085660
An Ad-Tech firm providing digital marketing, SEO, social media, and creative ad solutions.
South Korea 351870
CHAMPIONS ONCOLOGY, INC. Logo
Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.
United States of America CSBR

Talk to a Data Expert

Have a question? We'll get back to you promptly.